The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

BACKGROUND: Nafamostat mesilate decreases the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, no studies have administered nafamostat mesilate after ERCP. So we investigated if the infusion of nafamostat mesilate after ERCP can affect the post-ERCP pan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joo Seong, Lee, Sang Hyub, Park, Namyoung, Huh, Gunn, Chun, Jung Won, Choi, Jin Ho, Cho, In Rae, Paik, Woo Hyun, Ryu, Ji Kon, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153157/
https://www.ncbi.nlm.nih.gov/pubmed/35641898
http://dx.doi.org/10.1186/s12876-022-02345-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153157/
https://www.ncbi.nlm.nih.gov/pubmed/35641898
http://dx.doi.org/10.1186/s12876-022-02345-3

Ejemplares similares